Allied Market Research

2024

Global Therapeutic Vaccines Market

Global Therapeutic Vaccines Market Size, Share, Competitive Landscape and Trend Analysis Report by Type and by Application : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Pharmaceuticals

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Therapeutic vaccines are provided to the body during treatment of specific diseases. This vaccine triggers and strengthens the immune response of the body to act against a disease. In 2011, the global therapeutic vaccines market was valued at $294 million. This vaccine has expanded the horizon of chronic disease treatment. However, there is a need to get a vaccine for specific disease to be approved by the FDA. Increasing cases of chronic diseases and need for effective treatment is acting as key driver for this market. Various pharmaceutical companies are working to develop novel vaccines for diseases such as lung cancer, breast cancer, Alzheimer, etc. However, these vaccine developments are in pipeline and yet to be commercialized.

Inefficient Research & development and reimbursement policies are primary factors restraining the market. Furthermore, as the market is in nascent stage, strict regulatory implications are also expected to deter growth. However, as the vaccine carries potential to treat many chronic diseases, these restraints would get weaker with time. This report delivers micro level analysis of the therapeutic vaccine market and its opportunities in various disease treatments.

Key market players profiled in this report include Affiris, Antigenics, Argos Therapeutics, Bavarian Nordic, Biovest International, Celldex Therapeutics, Cel-Sci, Celtic Pharma, Curevac And Cytos Biotechnology.

KEY BENEFITS 

  • The report provides strategic analysis of the current market trend and delivers expected trends that would assist stakeholders to take strategic and actionable decisions
  • Present market quantitative scenario and estimations
  • Analysis of the market factors in various geographic regions and help understand business opportunities
  • Identification of key investment pockets for various applications, services and geographies
  • Identification of key players and their business performance analysis based on strategies followed by them
  • Identification of key application segments based on future potential and growth prospects¬†
  • Top factors affecting the market and analysis of probable changes in impact of those factors
  • Analysis and evaluation of market trends to provide deep-dive intelligence into every market segment
  • Competitive analysis based on strategies followed by key players to effectively plan and execute business plan
  • Micro level analysis based on application, service and geography

Global Therapeutic Vaccines Market Report Highlights

Aspects Details
icon_5
By Type
  • Protein-based Vaccines
  • DNA Vaccines
  • Recombinant Vector Vaccines
  • Conjugate Vaccines
  • Live Attenuated Vaccines
icon_6
By Application
  • Cancer
  • HIV/AIDS Vaccines
  • Infectious Diseases Vaccines
  • Allergy Vaccines
  • Others
icon_7
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Russia, Rest Of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Indonesia, Rest of Asia Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Argentina, Rest of LAMEA)
icon_8
Key Market Players

GlaxoSmithKline, Merck & Co., CSL Limited, Sanofi, Johnson & Johnson, Medimmune, Pfizer, Novartis, AstraZeneca, Dynavax Technologies Corporation

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Global Therapeutic Vaccines Market

Global Opportunity Analysis and Industry Forecast, 2023-2032